Progenesis MALDI software references

Note: Up until December 2008 Progenesis MALDI was supplied as Progenesis PG600.

2011

Leymarie N, McComb M, Naimy H, Staples G, Zaia, J. Differential Characterization and Classification of Tissue Specific Glycosaminoglycans by Tandem Mass Spectrometry and Statistical Methods. Int J Mass Spectrom 2011, publication in press.

Green-Church KB, Chen J, Nichols KK. Comparison Of Mass Spectrometry Lipid Profiles Of Meibum From Dry Eye And Normal Patients Using Electrospray Ionization And Matrix-assisted Laser Desorption Ionization. Invest Ophthalmol Vis Sci 2011;52: E-Abstract 3736.

2010

Sideso E, Papadakis M, Wright C, Handa A, Buchan A, Kessler B, Kennedy J,. Assessing the Quality and Reproducibility of a Proteomic Platform for Clinical Stroke Biomarker Discovery. Transl. Stroke Res. (2010) 1:304–314.

2007

Lopez M F et al (2007) A Novel, High-Throughput Workflow for Discovery and Identification of Serum Carrier Protein-Bound Peptide Biomarker Candidates in Ovarian Cancer Samples. Clinical Chemistry, 53:1067-1074

Lotan Y, Svatek R S, Nandi A, Gurnani P (2007) 513 Prospective Evaluation of Proteomics to Discriminate Between Benign and Malignant Prostate in Men with PSA Less Than 10 Eur. Urol. Suppl., 6(2):151